mississippi semaglutide Louisiana lawmakers are considering a bill that would expand Medicaid access to GLP-1 drugs for obesity treatment, a move supporters say could improve health outcomes and reduce long-term costs. https://bit.ly/4usEGVI Oral Wegovy Weight-Loss Treatment &

Patel A, MacMahon S, Chalmers J et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Best use cases include joint discomfort, slow healing, metabolic slowdown, skin aging, hair thinning, and chronic Peptides are amplifiers they multiply good habits like sleep, protein intake, and strength training

declares having received research grants from Boehringer Ingelheim, Merck, Mylan Pharmaceuticals, Novo Nordisk, Pfizer and Sanofi US Services

Dietary fat-associated osteoarthritic chondrocytes gain resistance to lipotoxicity through PKCK2/STAMP2/FSP27

While one is approved for weight loss (Wegovy) and the other for type 2 diabetes (Mounjaro), their mechanisms of action are quite similar, and both affect weight and blood sugar